Indegene Ltd (INDGN) is currently trading at 480.20 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Indegene Limited is a digital-first life sciences commercialization company focusing on enabling biopharmaceutical and medical device companies to develop and launch products more efficiently. Their core areas are digital marketing operations, medical, and regulatory operations. Indegene has embraced Generative AI through its Cortex platform, deploying AI-driven applications to enhance efficiency and effectiveness in life sciences operations, indicating a commitment to leveraging cutting-edge technology for client solutions. Recent strategic acquisitions, such as BioPharm and WARN & Co, enhance Indegene’s capabilities in targeting specialized healthcare markets and consulting, notably expanding their global reach and service offerings. Capacity expansion with new centers in Hyderabad, Spain, and London, aimed at scaling operations and supporting an AI-first approach, underscores Indegene's strategic focus on geographical and service enhancement. Indegene is capitalizing on strategic partnerships with hyperscalers to advance their GenAI solutions, reinforcing their market position as a pioneer in digital transformation for the life sciences industry.

Over the past 52 weeks, Indegene Ltd has traded between a low of ₹471.45 and a high of ₹665.95. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Indegene Ltd has a market capitalization of approximately 11,515.95. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Indegene Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.83 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Indegene Ltd (INDGN) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 11,515.95 Cr, Indegene Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Indegene Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Indegene Ltd is 25.83. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Indegene Ltd pays dividends with a current dividend yield of 0.42%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Indegene Ltd include sector-specific challenges in the Healthcare industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.